Frontier Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,610
Closed -$488K 348
2016
Q3
$488K Sell
10,610
-1,576
-13% -$72.5K ﹤0.01% 303
2016
Q2
$612K Sell
12,186
-1,167
-9% -$58.6K 0.01% 298
2016
Q1
$715K Sell
13,353
-1,767
-12% -$94.6K 0.01% 304
2015
Q4
$992K Sell
15,120
-3,657
-19% -$240K 0.01% 314
2015
Q3
$1.06M Sell
18,777
-5,823
-24% -$329K 0.01% 313
2015
Q2
$1.45M Hold
24,600
0.01% 318
2015
Q1
$1.53M Sell
24,600
-25,678
-51% -$1.6M 0.01% 319
2014
Q4
$2.89M Buy
50,278
+1,192
+2% +$68.5K 0.02% 315
2014
Q3
$2.64M Buy
49,086
+560
+1% +$30.1K 0.02% 303
2014
Q2
$2.54M Sell
48,526
-20,955
-30% -$1.1M 0.02% 303
2014
Q1
$3.67M Buy
69,481
+2,521
+4% +$133K 0.03% 306
2013
Q4
$2.68M Sell
66,960
-7,620
-10% -$305K 0.02% 302
2013
Q3
$2.82M Sell
74,580
-7,500
-9% -$283K 0.02% 310
2013
Q2
$3.22M Buy
+82,080
New +$3.22M 0.03% 312